Outdoor-Use Test for Sunscreen Products in Children Ages 3 to 9 Years Old
NCT02831478 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98
Last updated 2018-12-12
Summary
To assess the safety of a sunscreen product under supervised outdoor-use conditions with the target consumer
Conditions
- Sunscreening Agent
Interventions
- DRUG
-
BAY987517
Applied liberally to the skin (Formulation: RB# Z16-071)
- DRUG
-
Sunscreen Lotion (RB# T78-190B)
Applied liberally to the skin
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 3 Years
- Max Age
- 9 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-07-09
- Primary Completion
- 2016-07-10
- Completion
- 2016-07-10
Countries
- United States
Study Locations
More Related Trials
-
Human Phototoxicity Test (823/2016)
NCT02962856 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic (PK) Evaluation of Bemotrizinol (6%) in a Sunscreen Maximum Usage Trial
NCT05277376 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic Function
NCT05283915 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-Finding of Retinoid 9cUAB30 in Healthy Volunteers
NCT01336387 ·Status: TERMINATED ·Phase: PHASE1
-
A STUDY TO COMPARE THE PHARMACOKINETICS OF PF-06835919 IN PARTICIPANTS WITH AND WITHOUT HEPATIC IMPAIRMENT
NCT04193436 ·Status: COMPLETED ·Phase: PHASE1
-
Phototoxicity of Frequently Prescribed Medicines
NCT06710600 ·Status: COMPLETED ·Phase: NA
-
Kinetic Time Courses of Bisphenol-S in Volunteers
NCT03340168 ·Status: UNKNOWN ·Phase: NA
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BP101 in Healthy Volunteers
NCT03102489 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1805-R1 and NVP-1805-R2
NCT03802526 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare a Single-dose of Two Different Formulations of ACT-709478 in Healthy Men
NCT04123288 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of RBT-9 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease
NCT04072861 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability Study of MCI-196
NCT01818687 ·Status: TERMINATED ·Phase: PHASE3
-
A Single-dose, Open-label, Pharmacokinetic Study of Belapectin (GR-MD-02) in Subjects With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment
NCT04332432 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire
NCT03080298 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years
NCT06993636 ·Status: RECRUITING
-
Evaluation Of Hepatic Impairment On AG-013736 Pharmacokinetics
NCT00692341 ·Status: COMPLETED ·Phase: PHASE1
-
Olmesartan Pediatric Pharmacokinetic (PK) Study
NCT00151814 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of TAK-279 in Adults With or Without Liver Damage
NCT05976321 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Multiple Oral Dose of TAK-418 in Healthy Female Participants
NCT03501069 ·Status: TERMINATED ·Phase: PHASE1
-
To Investigate Pharmacokinetics (Absorption, Distribution, Elimination), Safety and Tolerability of a Single Oral Dose of 75 mg Molidustat Tablet in Male and Female Subjects Requiring Hemo- or Peritoneal Dialysis Compared to Healthy Subjects
NCT02312973 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
NCT06357910 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-G3031 in Healthy Subjects
NCT02881294 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions
NCT03603106 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Two Macitentan Pediatric Formulations in Healthy Adult Participants
NCT04963439 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers
NCT01711762 ·Status: COMPLETED ·Phase: PHASE1